Condition: Multiple Sclerosis · Clinically Isolated Syndrome · Sponsor: University Hospital, Bordeaux
The study aims at identifying the type of B and CD4 T cell subsets with pathogenic properties in the different clinical forms of multiple sclerosis. This research might open new therapeutic approaches for the treatment of multiple sclerosis particularly progressive MS.
This description comes directly from the study's public registry record.
Aurélie RUET, Prof · 05 56 79 55 21 · aurelie.ruet@chu-bordeaux.fr
Always discuss trial participation with your own doctor first.
| CHU de Bordeaux - service de neurologie | Bordeaux, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04798651